Literature DB >> 23498380

"Thinking about it for somebody else": Alzheimer's disease research and proxy decision makers' translation of ethical principles into practice.

Laura B Dunn1, Stephanie Reyes Fisher, Melinda Hantke, Paul S Appelbaum, Daniel Dohan, Jenifer P Young, Laura Weiss Roberts.   

Abstract

OBJECTIVES: Ethical guidelines suggest that, when enrolling patients with dementia in research, alterative decision makers (proxies) should base their decision on a "substituted judgment" of how the patient would have decided. If unable to make a substituted judgment, proxies are asked to decide on the basis of the patient's best interests. This mixed-methods study is the first to examine explicitly whether and to what degree proxies differentiate between these two approaches and what considerations influence their mode of decision making.
DESIGN: Interview study regarding enrollment of relative in hypothetical clinical trial of an investigational drug for Alzheimer disease. Participants were randomized to respond to questions about one of four hypothetical clinical trials that differed by levels of described risk and potential benefit. PARTICIPANTS: Proxy decision makers (N = 40). MEASUREMENTS: Open-ended and rating-scaled items.
RESULTS: Half of the proxies agreed with both of two rating-scaled items asking about different approaches to decision making-that is, agreeing that they would decide on the basis of how their relative would have decided and agreeing that they would decide on the basis of what they believed was in their relative's best interests. Narrative responses elaborated on themes within the following three major domains: Substituted judgment, best interests, and weighing substituted judgment and best interests. Substituted judgment was framed as honoring the patient's wishes and values. Best interests was described as a perceived duty to maintain quality of life and avoid burdens or risks. Weighing the two standards emerged as a challenging yet important, way of honoring wishes while maintaining quality of life. An unexpected theme was the attempt by alternative decision makers to discern their loved one's current versus premorbid research preferences.
CONCLUSIONS: Tensions exist between abstract ethical principles regarding decision-making "standards" and their translation into research decisions.
Copyright © 2013 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23498380      PMCID: PMC3381872          DOI: 10.1016/j.jagp.2012.11.014

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  21 in total

1.  Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research.

Authors:  S Y Kim; E D Caine; G W Currier; A Leibovici; J M Ryan
Journal:  Am J Psychiatry       Date:  2001-05       Impact factor: 18.112

Review 2.  Alzheimer's disease and its management in the year 2010.

Authors:  J L Cummings; D V Jeste
Journal:  Psychiatr Serv       Date:  1999-09       Impact factor: 3.084

3.  Alzheimer's disease patients' and caregivers' capacity, competency, and reasons to enroll in an early-phase Alzheimer's disease clinical trial.

Authors:  Jason H T Karlawish; David J Casarett; Bryan D James
Journal:  J Am Geriatr Soc       Date:  2002-12       Impact factor: 5.562

4.  How do AD patients and their caregivers decide whether to enroll in a clinical trial?

Authors:  J H Karlawish; D Casarett; J Klocinski; P Sankar
Journal:  Neurology       Date:  2001-03-27       Impact factor: 9.910

5.  Informed consent for Alzheimer's disease clinical trials: a survey of clinical investigators.

Authors:  Jason H T Karlawish; David Knopman; Christopher M Clark; John C Morris; Daniel Marson; Peter J Whitehouse; Claudia H Kawas
Journal:  IRB       Date:  2002 Sep-Oct

6.  Qualitative data analysis for health services research: developing taxonomy, themes, and theory.

Authors:  Elizabeth H Bradley; Leslie A Curry; Kelly J Devers
Journal:  Health Serv Res       Date:  2007-08       Impact factor: 3.402

7.  How proxies make decisions about research for patients with Alzheimer's disease.

Authors:  J Sugarman; C Cain; R Wallace; K A Welsh-Bohmer
Journal:  J Am Geriatr Soc       Date:  2001-08       Impact factor: 5.562

8.  Ethical aspects of dementia research: informed consent and proxy consent.

Authors:  G A Sachs; C B Stocking; R Stern; D M Cox; G Hougham; R S Sachs
Journal:  Clin Res       Date:  1994-10

Review 9.  Treatment of Alzheimer's disease: current and future therapeutic approaches.

Authors:  Jeffrey L Cummings
Journal:  Rev Neurol Dis       Date:  2004

10.  The Global Deterioration Scale for assessment of primary degenerative dementia.

Authors:  B Reisberg; S H Ferris; M J de Leon; T Crook
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

View more
  8 in total

1.  Attitudes of Mothers Regarding Willingness to Enroll Their Children in Research.

Authors:  Jane Paik Kim; Maryam Rostami; Laura Weiss Roberts
Journal:  J Empir Res Hum Res Ethics       Date:  2020-06-18       Impact factor: 1.742

2.  Do human subject safeguards matter to potential participants in psychiatric genetic research?

Authors:  Laura Weiss Roberts; Jane Paik Kim; Tenzin Tsungmey; Laura B Dunn
Journal:  J Psychiatr Res       Date:  2019-06-08       Impact factor: 4.791

3.  Are individuals living with mental illness and their preferred alternative decision-makers attuned and aligned in their attitudes regarding treatment decisions?

Authors:  Laura Weiss Roberts; Jane Paik Kim
Journal:  J Psychiatr Res       Date:  2016-03-15       Impact factor: 4.791

Review 4.  Reconsidering Gold Standards for Surrogate Decision Making for People with Dementia.

Authors:  James M Wilkins
Journal:  Psychiatr Clin North Am       Date:  2021-12

5.  (Re)Conceptualising 'good' proxy decision-making for research: the implications for proxy consent decision quality.

Authors:  Victoria Shepherd
Journal:  BMC Med Ethics       Date:  2022-07-18       Impact factor: 2.834

6.  Researchers' perspectives on the role of study partners in dementia research.

Authors:  Betty S Black; Holly Taylor; Peter V Rabins; Jason Karlawish
Journal:  Int Psychogeriatr       Date:  2014-07-03       Impact factor: 3.878

7.  Informed consent, therapeutic misconception, and clinical trials for Alzheimer's disease.

Authors:  James M Wilkins; Brent P Forester
Journal:  Int J Geriatr Psychiatry       Date:  2020-01-26       Impact factor: 3.485

8.  Positive Attitudes and Therapeutic Misconception Around Hypothetical Clinical Trial Participation in the Huntington's Disease Community.

Authors:  Kristina Cotter; Carly E Siskind; Sharon J Sha; Andrea K Hanson-Kahn
Journal:  J Huntingtons Dis       Date:  2019
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.